Igor Khaliulin Selected Research

Igor Khaliulin Research Topics

Disease

14	Ischemia 01/2021 - 07/2003
10	Reperfusion Injury 02/2022 - 06/2007
7	Infarction (Infarctions) 02/2022 - 06/2011
2	Necrosis 01/2016 - 08/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 10/2004
1	Autistic Disorder (Autism) 11/2023
1	Neoplasms (Cancer) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 10/2023
1	Pathologic Processes 11/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Brain Diseases (Brain Disorder) 01/2020
1	Hyperemia 11/2019
1	Hyperventilation 11/2019
1	Tachycardia (Tachyarrhythmias) 12/2012
1	Hypothermia 06/2011
1	Parkinson Disease (Parkinson's Disease) 05/2006
1	Myocardial Reperfusion Injury 07/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2003
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2018 - 08/2007
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2022 - 08/2007
3	Adenosine (Adenocard)FDA LinkGeneric 02/2018 - 06/2011
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2018 - 06/2011
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 05/2008 - 07/2004
3	Apomorphine FDA Link 05/2006 - 07/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 01/2020
2	Opioid Receptors (Opioid Receptor)IBA 09/2021 - 01/2016
2	Opioid Analgesics (Opioids)IBA 09/2021 - 01/2016
2	Mitochondrial Permeability Transition PoreIBA 01/2021 - 08/2007
2	GlycogenIBA 02/2018 - 05/2014
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 12/2012
2	CalciumIBA 05/2008 - 08/2007
2	Nicorandil (SG 75)IBA 05/2005 - 07/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2005 - 10/2003
1	7-nitroindazoleIBA 11/2023
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2023
1	erythromycin propionate-N-acetylcysteinateIBA 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Endothelin-1 (Endothelin 1)IBA 01/2022
1	D-Penicillamine (2,5)- EnkephalinIBA 09/2021
1	N-methylnaloxoneIBA 09/2021
1	norbinaltorphimineIBA 09/2021
1	Ala(2)- deltorphin IIIBA 09/2021
1	naltrindole benzofuranIBA 09/2021
1	Naltrexone (ReVia)FDA LinkGeneric 09/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 09/2021
1	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 09/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Protein SIBA 01/2020
1	Sulfhydryl Compounds (Thiols)IBA 01/2020
1	PorphyrinsIBA 11/2019
1	salicylhydroxamic acid (SHAM)IBA 11/2019
1	Liposomes (Liposome)IBA 01/2018
1	CannabinoidsIBA 01/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	LigandsIBA 01/2016
1	Cannabinoid Receptor AgonistsIBA 01/2016
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2012
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2011
1	Procaine (Novocaine)FDA LinkGeneric 06/2011
1	Cyclic AMP (AMP, Cyclic)IBA 06/2011
1	PhosphoproteinsIBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 05/2008
1	Protein Isoforms (Isoforms)IBA 05/2008
1	Glycogen Synthase Kinase 3 betaIBA 05/2008
1	Glycogen Synthase KinasesIBA 05/2008
1	Voltage-Dependent Anion ChannelsIBA 05/2008
1	Protein Kinase C-alphaIBA 05/2008
1	AMP-Activated Protein KinasesIBA 05/2008
1	UrocortinsIBA 08/2007
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2007
1	Apolipoproteins AIBA 05/2006
1	AntioxidantsIBA 05/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2006
1	Ubiquitinated ProteinsIBA 05/2005
1	Phosphates (Orthophosphate)IBA 01/2005
1	SolutionsIBA 01/2005
1	Saline SolutionIBA 01/2005
1	Insulin (Novolin)FDA Link 10/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2003

Therapy/Procedure

1	Therapeutics 01/2021
1	Ischemic Postconditioning 01/2016
1	TP protocol 06/2011
1	Transplantation 06/2011
1	Induced Heart Arrest (Cardioplegia) 06/2011
1	Rewarming 06/2007